GGrantIndex
← Leaderboards

Page Buckhannan Pennell

University Of Minnesota

$12,920,589
Attributed
$30,497,462
Total exposure
6
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.6M · FY200625
$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$30,497,462 · 6

By mechanism

U01$27,658,468 · 1
R01$2,202,494 · 1
UE5$423,645 · 1
R03$204,426 · 1
M01$8,429 · 1
P50$0 · 1

Most similar at University Of Minnesota

Same institution · by research overlap

Others in their field

Top investigators on “Epilepsy

Research focus

EpilepsyPregnancyWomanGrantMothersAffectExposure ToSeizuresProspectivePreventCongenital AbnormalityDoseChildLamotrigineDrug ExposureCohortAntiepileptic AgentsBreast FeedingPregnant WomenCognitiveInfantControlled StudyIn UteroNervous System Disorder

Grant awards (22)

Physiological-based Pharmacokinetics Approach to Determine the Extent of Drug Exposure of Antiseizure Medications During Pregnancy and Breastfeeding$546,216
R01 · FY2025 · HD
N3-PREP (Neurology, Neurosurgery, & Neuropathology Pitt Research Education Program)$207,749
UE5 · FY2025 · NS · contact PI
Physiological-based Pharmacokinetics Approach to Determine the Extent of Drug Exposure of Antiseizure Medications During Pregnancy and Breastfeeding$539,430
R01 · FY2024 · HD
N3-PREP (Neurology, Neurosurgery, & Neuropathology Pitt Research Education Program)$215,896
UE5 · FY2024 · NS · contact PI
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)$1,924,297
U01 · FY2022 · NS
Physiological-based Pharmacokinetics Approach to Determine the Extent of Drug Exposure of Antiseizure Medications During Pregnancy and Breastfeeding$550,360
R01 · FY2022 · HD
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)$2,576,269
U01 · FY2021 · NS
Physiological-based Pharmacokinetics Approach to Determine the Extent of Drug Exposure of Antiseizure Medications During Pregnancy and Breastfeeding$566,488
R01 · FY2021 · HD
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)$3,180,681
U01 · FY2020 · NS
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)$2,902,630
U01 · FY2019 · NS
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)$3,599,894
U01 · FY2018 · NS
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)$121,409
U01 · FY2017 · NS
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)$3,171,989
U01 · FY2016 · NS
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)$1,128,930
U01 · FY2015 · NS
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)$2,844,126
U01 · FY2014 · NS
Investigates the metabolomic indicators of neurodevelop risk in children of pregnant women with epilepsy$176,309
U01 · FY2014 · NS
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)$2,860,622
U01 · FY2013 · NS
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)$3,171,312
U01 · FY2012 · NS
Neuroactive Steroids and Seizure Control during Pregnancy in Women with Epilepsy$101,800
R03 · FY2010 · NS · contact PI
Neuroactive Steroids and Seizure Control during Pregnancy in Women with Epilepsy$102,626
R03 · FY2009 · NS · contact PI
METABOLISM OF ANTIEPILEPTIC DRUGS$8,429
M01 · FY2006 · RR · contact PI
Epilepsy and Childbirth: PK/PD Modeling of AEDs$0
P50 · FY2002 · MH